Conformational constraints for amyloid fibrillation: the importance of being unfolded.

[1]  M. Schiffer,et al.  Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains , 2008, Protein science : a publication of the Protein Society.

[2]  Vladimir N Uversky,et al.  A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.

[3]  V. Uversky,et al.  Partially folded intermediates in insulin fibrillation. , 2003, Biochemistry.

[4]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[5]  S. Radford,et al.  A systematic investigation into the effect of protein destabilisation on beta 2-microglobulin amyloid formation. , 2003, Journal of molecular biology.

[6]  C. Yu,et al.  Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation. , 2003, The Journal of biological chemistry.

[7]  V. Uversky,et al.  Nitration inhibits fibrillation of human α‐synuclein in vitro by formation of soluble oligomers , 2003 .

[8]  Theodore W Randolph,et al.  Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony‐stimulating factor , 2003, Protein science : a publication of the Protein Society.

[9]  Yuji Goto,et al.  Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond. , 2003, Biochemical and biophysical research communications.

[10]  R. L. Baldwin,et al.  Role of backbone solvation and electrostatics in generating preferred peptide backbone conformations: Distributions of phi , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Weston,et al.  Prevention of peptide fibril formation in an aqueous environment by mutation of a single residue to Aib. , 2003, Biochemistry.

[12]  R. Ribeiro,et al.  Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant. , 2003, Journal of molecular biology.

[13]  C. Masters,et al.  Diverse fibrillar peptides directly bind the Alzheimer’s amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation , 2003, Brain Research.

[14]  T. Koga,et al.  Structural regulation of a peptide-conjugated graft copolymer: a simple model for amyloid formation. , 2003, Chemistry.

[15]  P. Fraser,et al.  Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis. , 2003, Journal of structural biology.

[16]  H. Nakanishi,et al.  Effect of pH on the aggregate formation of a non‐amyloid component (1–13) , 2003, Journal of peptide science : an official publication of the European Peptide Society.

[17]  V. Uversky,et al.  Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.

[18]  J. Kelly,et al.  Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics , 2003, Science.

[19]  J. Torres,et al.  Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I* , 2003, The Journal of Biological Chemistry.

[20]  C. Dobson,et al.  In vitro characterization of lactoferrin aggregation and amyloid formation. , 2003, Biochemistry.

[21]  Robert G Griffin,et al.  Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Howlett,et al.  Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II. , 2002, Biochemistry.

[23]  H. Nakanishi,et al.  pH-dependent aggregate forms and conformation of Alzheimer amyloid beta-peptide (12-24). , 2002, Journal of biochemistry.

[24]  Andreas Hoenger,et al.  De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Vaux,et al.  Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. , 2002, Biochemistry.

[26]  L. Tjernberg,et al.  Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.

[27]  À. Argilés,et al.  BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. , 2002, European journal of biochemistry.

[28]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[29]  L. Iakoucheva,et al.  Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.

[30]  H. Kleinman,et al.  Ile‐Lys‐Val‐Ala‐Val (IKVAV)‐containing laminin α1 chain peptides form amyloid‐like fibrils , 2002, FEBS letters.

[31]  Lynne Regan,et al.  Does the location of a mutation determine the ability to form amyloid fibrils? , 2002, Journal of molecular biology.

[32]  N. Lockwood,et al.  Aqueous gel formation of a synthetic peptide derived from the beta-sheet domain of platelet factor-4. , 2002, Biomacromolecules.

[33]  H. E. Stanley,et al.  Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Dobson,et al.  Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS , 2002, FEBS letters.

[35]  P. Lansbury,et al.  Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.

[36]  P. Tompa.  Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.

[37]  G. Rose,et al.  A simple model for polyproline II structure in unfolded states of alanine‐based peptides , 2002, Protein science : a publication of the Protein Society.

[38]  Kiowa S. Bower,et al.  Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: implications for Parkinson's disease. , 2002, Neurotoxicology.

[39]  Vladimir N Uversky,et al.  Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. , 2002, Neurotoxicology.

[40]  C. Dobson,et al.  A kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea , 2002 .

[41]  V. Uversky,et al.  Conformational Prerequisites for α-Lactalbumin Fibrillation† , 2002 .

[42]  Meital Reches,et al.  Amyloid Fibril Formation by Pentapeptide and Tetrapeptide Fragments of Human Calcitonin* , 2002, The Journal of Biological Chemistry.

[43]  P. Nandi,et al.  DNA-induced partial unfolding of prion protein leads to its polymerisation to amyloid. , 2002, Journal of molecular biology.

[44]  D. Kirschner,et al.  Molecular organization of amyloid protofilament-like assembly of betabellin 15D: helical array of beta-sandwiches. , 2002, Biophysical journal.

[45]  Karin Romisch.  Faculty Opinions recommendation of Neurodegenerative disease: amyloid pores from pathogenic mutations. , 2002 .

[46]  Ž. Eva.  Amyloid-fibril formation: Proposed mechanisms and relevance to conformational disease , 2002 .

[47]  George D Rose,et al.  Polyproline II structure in a sequence of seven alanine residues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Radford,et al.  The yeast prion Ure2p retains its native α‐helical conformation upon assembly into protein fibrils in vitro , 2002, The EMBO journal.

[50]  K. Hasegawa,et al.  Conformation of β2-Microglobulin Amyloid Fibrils Analyzed by Reduction of the Disulfide Bond* , 2002, The Journal of Biological Chemistry.

[51]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[52]  H. M. Petrassi,et al.  Screening transthyretin amyloid fibril inhibitors: characterization of novel multiprotein, multiligand complexes by mass spectrometry. , 2002, Structure.

[53]  Mark R. Wilson,et al.  Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin. , 2002, European journal of biochemistry.

[54]  C. Dobson.  Protein folding and its links with human disease. , 2002, Biochemical Society symposium.

[55]  C. Yu,et al.  Amyloid-like Fibril Formation in an All β-Barrel Protein Involves the Formation of Partially Structured Intermediate(s)* , 2002, The Journal of Biological Chemistry.

[56]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[57]  V. Subramaniam,et al.  Amyloid fibrils from the mammalian protein prothymosin α , 2002 .

[58]  V. Uversky,et al.  Methionine oxidation inhibits fibrillation of human α‐synuclein in vitro , 2002 .

[59]  M. Perutz,et al.  Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  V. Uversky,et al.  Effect of Association State and Conformational Stability on the Kinetics of Immunoglobulin Light Chain Amyloid Fibril Formation at Physiological pH* , 2002, The Journal of Biological Chemistry.

[61]  V. Uversky,et al.  Elucidation of the Molecular Mechanism during the Early Events in Immunoglobulin Light Chain Amyloid Fibrillation , 2002, The Journal of Biological Chemistry.

[62]  V. Uversky.  Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.

[63]  B. Sivakumar,et al.  Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization. , 2002, Archives of biochemistry and biophysics.

[64]  Kiowa S. Bower,et al.  Accelerated α‐synuclein fibrillation in crowded milieu , 2002 .

[65]  Eliah Aronoff-Spencer,et al.  Molecular features of the copper binding sites in the octarepeat domain of the prion protein. , 2002, Biochemistry.

[66]  P. Lansbury,et al.  Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? , 2002, Biochemistry.

[67]  A. Minton,et al.  Macromolecular Crowding Accelerates Amyloid Formation by Human Apolipoprotein C-II* , 2002, The Journal of Biological Chemistry.

[68]  G. Howlett,et al.  The structural basis for amyloid formation by plasma apolipoproteins: a review , 2002, European Biophysics Journal.

[69]  H. Dyson,et al.  Coupling of folding and binding for unstructured proteins. , 2002, Current opinion in structural biology.

[70]  V. Uversky,et al.  Native-like secondary structure of molten globules. , 2002, Biochimica et biophysica acta.

[71]  V. Turk,et al.  Human stefin B readily forms amyloid fibrils in vitro. , 2002, Biochimica et biophysica acta.

[72]  A. Dubnovitsky,et al.  Amyloid fibril formation of the mouse V(L) domain at acidic pH. , 2002, Biochemistry.

[73]  V. Uversky,et al.  The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice , 2002, The Journal of Biological Chemistry.

[74]  J. Kelly,et al.  Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors. , 2002, Journal of medicinal chemistry.

[75]  M G Fried,et al.  Host-guest study of left-handed polyproline II helix formation. , 2001, Biochemistry.

[76]  C. Dobson,et al.  Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N‐terminal domain , 2001, Protein science : a publication of the Protein Society.

[77]  V. Uversky,et al.  Trimethylamine‐N‐oxide‐induced folding of α‐synuclein , 2001 .

[78]  A. Clark,et al.  Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. , 2001, Biochimica et biophysica acta.

[79]  V. Uversky,et al.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.

[80]  S. Lindquist,et al.  The role of conformational flexibility in prion propagation and maintenance for Sup35p , 2001, Nature Structural Biology.

[81]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[82]  B. Lin,et al.  The mechanism of oxidation-induced low-density lipoprotein aggregation: an analogy to colloidal aggregation and beyond? , 2001, Biophysical journal.

[83]  C. Link,et al.  Transgenic invertebrate models of age-associated neurodegenerative diseases , 2001, Mechanisms of Ageing and Development.

[84]  J. Kelly,et al.  Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy. , 2001, Biochemistry.

[85]  J. Carver,et al.  The Molecular Chaperone, α-Crystallin, Inhibits Amyloid Formation by Apolipoprotein C-II* , 2001, The Journal of Biological Chemistry.

[86]  N. Heegaard,et al.  Conformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH* , 2001, The Journal of Biological Chemistry.

[87]  V. Uversky,et al.  Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.

[88]  H. M. Petrassi,et al.  An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. , 2001, Biochemistry.

[89]  V. Uversky,et al.  Denatured collapsed states in protein folding: Example of apomyoglobin , 2001, Proteins.

[90]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[91]  J. Johansson.  Membrane properties and amyloid fibril formation of lung surfactant protein C. , 2001, Biochemical Society transactions.

[92]  V. Uversky,et al.  Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.

[93]  B. Bevis,et al.  The assembly of amyloidogenic yeast sup35 as assessed by scanning (atomic) force microscopy: an analogy to linear colloidal aggregation? , 2001, Biophysical journal.

[94]  G. Vriend,et al.  Amyloid‐like fibrils from an 18‐residue peptide analogue of a part of the central domain of the B‐family of silkmoth chorion proteins , 2001, FEBS letters.

[95]  V. Uversky,et al.  Probing the mechanism of insulin fibril formation with insulin mutants. , 2001, Biochemistry.

[96]  M. Saraiva.  Transthyretin amyloidosis: a tale of weak interactions , 2001, FEBS letters.

[97]  M. Goedert.  The significance of tau and α-synuclein inclusions in neurodegenerative diseases , 2001 .

[98]  G. Howlett,et al.  NMR structure of human apolipoprotein C-II in the presence of sodium dodecyl sulfate. , 2001, Biochemistry.

[99]  P E Fraser,et al.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.

[100]  K. Fischbeck,et al.  Polyglutamine and CBP: Fatal attraction? , 2001, Nature Medicine.

[101]  C. Dobson,et al.  Amyloid fibril formation by a helical cytochrome , 2001, FEBS letters.

[102]  Michel Goedert,et al.  Parkinsons Disease and other α-Synucleinopathies , 2001 .

[103]  V. Uversky,et al.  Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.

[104]  G. Howlett,et al.  Sub‐micellar phospholipid accelerates amyloid formation by apolipoprotein C‐II , 2001, FEBS letters.

[105]  V. Uversky,et al.  Evidence for a Partially Folded Intermediate in α-Synuclein Fibril Formation* , 2001, The Journal of Biological Chemistry.

[106]  C. Dobson,et al.  Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation , 2001, Protein science : a publication of the Protein Society.

[107]  Christopher M. Dobson,et al.  Amyloid fibrils from muscle myoglobin , 2001, Nature.

[108]  C. Ionescu-Zanetti,et al.  Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. , 2001, Biochemistry.

[109]  C. Dobson.  The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[110]  A. Komar,et al.  Stability, folding, dimerization, and assembly properties of the yeast prion Ure2p. , 2001, Biochemistry.

[111]  G. Asano,et al.  α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation , 2001, Brain Research.

[112]  D. Selkoe,et al.  A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils , 2000, Nature Structural Biology.

[113]  P. Lansbury,et al.  Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants , 2000 .

[114]  V. Uversky,et al.  Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.

[115]  F. Cohen,et al.  Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. , 2000, Biochemistry.

[116]  T. Fath,et al.  Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. , 2000, Biochemistry.

[117]  E. Wanker.  Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations , 2000, Biological chemistry.

[118]  K. Fischbeck,et al.  CREB-binding protein sequestration by expanded polyglutamine. , 2000, Human molecular genetics.

[119]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[120]  A. Doig,et al.  Is polyproline II helix the killer conformation? A Raman optical activity study of the amyloidogenic prefibrillar intermediate of human lysozyme. , 2000, Journal of molecular biology.

[121]  A. Koide,et al.  Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. , 2000, Journal of molecular biology.

[122]  S. Radford,et al.  Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro. , 2000, Biochemistry.

[123]  L. Regan,et al.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[124]  L. Serpell,et al.  The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.

[125]  C M Dobson,et al.  Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. , 2000, Journal of molecular biology.

[126]  C. MacPhee,et al.  Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. , 2000, Biochemistry.

[127]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[128]  R. Crowther,et al.  Abnormal tau-containing filaments in neurodegenerative diseases. , 2000, Journal of structural biology.

[129]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[130]  G. Merlini,et al.  Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. , 2000, Journal of structural biology.

[131]  C. Dobson,et al.  Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants. , 2000, Journal of structural biology.

[132]  L. Berliner,et al.  α‐Lactalbumin: structure and function , 2000 .

[133]  H. Fabian,et al.  Conversion of yeast phosphoglycerate kinase into amyloid‐like structure , 2000, Proteins.

[134]  C. Dobson,et al.  Biophysical studies of the development of amyloid fibrils from a peptide fragment of cold shock protein B. , 2000, European journal of biochemistry.

[135]  C. Cotman,et al.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide , 2000 .

[136]  C M Dobson,et al.  Mutational analysis of the propensity for amyloid formation by a globular protein , 2000, The EMBO journal.

[137]  James C. Sacchettini,et al.  Rational design of potent human transthyretin amyloid disease inhibitors , 2000, Nature Structural Biology.

[138]  H. Zoghbi,et al.  Fourteen and counting: unraveling trinucleotide repeat diseases. , 2000, Human molecular genetics.

[139]  P E Fraser,et al.  Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid‐like fibrils , 2000, FEBS letters.

[140]  K. Namba,et al.  The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus. , 2000, Biochemistry.

[141]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[142]  G. Arlaud,et al.  A peptide from the adenovirus fiber shaft forms amyloid‐type fibrils , 2000, FEBS letters.

[143]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[144]  M. Manning,et al.  Thermodynamic Modulation of Light Chain Amyloid Fibril Formation* , 2000, The Journal of Biological Chemistry.

[145]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[146]  C. Ionescu-Zanetti,et al.  Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[147]  S Doniach,et al.  Natively unfolded human prothymosin alpha adopts partially folded collapsed conformation at acidic pH. , 1999, Biochemistry.

[148]  V. Uversky,et al.  Protein deposits as the molecular basis of amyloidosis. Part II . Localizated amyloidosis and neurodegenerative disorders , 1999 .

[149]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[150]  H. Zoghbi,et al.  Polyglutamine diseases: protein cleavage and aggregation , 1999, Current Opinion in Neurobiology.

[151]  M. Schell,et al.  Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.

[152]  M. Hecht,et al.  De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[153]  C. Wurth,et al.  The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions. , 1999, Biochemistry.

[154]  A. Alexandrescu,et al.  An NMR investigation of solution aggregation reactions preceding the misassembly of acid-denatured cold shock protein A into fibrils. , 1999, Journal of molecular biology.

[155]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[156]  J. Collinge,et al.  Structural mobility of the human prion protein probed by backbone hydrogen exchange , 1999, Nature Structural Biology.

[157]  K. Murata,et al.  Amyloid‐like aggregates of a plant protein: a case of a sweet‐tasting protein, monellin , 1999, FEBS letters.

[158]  D. Housman,et al.  Evidence for a recruitment and sequestration mechanism in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[159]  R. Seckler,et al.  Formation of Fibrous Aggregates from a Non-native Intermediate: The Isolated P22 Tailspike β-Helix Domain* , 1999, The Journal of Biological Chemistry.

[160]  R. Glockshuber,et al.  Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates , 1999, Nature Structural Biology.

[161]  V. Bellotti,et al.  Biological activity and pathological implications of misfolded proteins , 1999, Cellular and Molecular Life Sciences CMLS.

[162]  A. Komar,et al.  Structural Characterization of Saccharomyces cerevisiae Prion-like Protein Ure2* , 1999, The Journal of Biological Chemistry.

[163]  C. Redfield.  Molten globules , 1999, Current Biology.

[164]  C. Dobson,et al.  Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants. , 1999, Biochemistry.

[165]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[166]  M. Citron,et al.  Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.

[167]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[168]  P. Lansbury.  Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[169]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[170]  P. Tucker,et al.  The glutamine-rich domain of the Drosophila GAGA factor is necessary for amyloid fibre formation in vitro, but not for chromatin remodelling. , 1999, Journal of molecular biology.

[171]  J. Kelly,et al.  Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors. , 1999, Bioorganic & medicinal chemistry letters.

[172]  V. Uversky,et al.  Hyperphosphorylation induces structural modification of tau‐protein , 1998, FEBS letters.

[173]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[174]  Scott A. Peterson,et al.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[175]  Scott A. Peterson,et al.  Discovering transthyretin amyloid fibril inhibitors by limited screening. , 1998, Bioorganic & medicinal chemistry.

[176]  S. Aota,et al.  Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. , 1998, Journal of molecular biology.

[177]  T. Yamazaki,et al.  Solution structure of thermostable cytochrome c-552 from Hydrogenobacter thermophilus determined by 1H-NMR spectroscopy. , 1998, Biochemistry.

[178]  B. W. Erickson,et al.  Engineering of betabellin‐15d: A 64 residue beta sheet protein that forms long narrow multimeric fibrils , 1998, Protein science : a publication of the Protein Society.

[179]  J. Weissman,et al.  A Critical Role for Amino-Terminal Glutamine/Asparagine Repeats in the Formation and Propagation of a Yeast Prion , 1998, Cell.

[180]  D. Teplow,et al.  Structural and kinetic features of amyloid beta-protein fibrillogenesis. , 1998, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[181]  V. Uversky,et al.  Anion-induced folding of Staphylococcal nuclease: characterization of multiple equilibrium partially folded intermediates. , 1998, Journal of molecular biology.

[182]  I D Campbell,et al.  Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[183]  C. Dobson,et al.  Conformational stability of muscle acylphosphatase: the role of temperature, denaturant concentration, and pH. , 1998, Biochemistry.

[184]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[185]  A. Fink.  Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[186]  P. Lansbury,et al.  Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. , 1997, Chemistry & biology.

[187]  V. Uversky,et al.  Sequential Compaction of a Random Copolymer of Hydrophilic and Hydrophobic Amino Acid Residues , 1997 .

[188]  V. Uversky.  Diversity of equilibrium compact forms of denatured globular proteins , 1997, Protein & Peptide Letters.

[189]  R. Wickner,et al.  The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[190]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[191]  E. Stellwagen,et al.  The role of PII conformations in the calculation of peptide fractional helix content , 1997, Protein science : a publication of the Protein Society.

[192]  M. Jadoul,et al.  Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. , 1997, Kidney international.

[193]  S. Lindquist,et al.  Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.

[194]  S. Lindquist,et al.  Mad Cows Meet Psi-chotic Yeast: The Expansion of the Prion Hypothesis , 1997, Cell.

[195]  J. Brange,et al.  Toward understanding insulin fibrillation. , 1997, Journal of pharmaceutical sciences.

[196]  M. Billingsley,et al.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. , 1997, The Biochemical journal.

[197]  S. Radford,et al.  Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes , 1997, Nature.

[198]  D. Selkoe,et al.  Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.

[199]  P. Nordlund,et al.  Crystal structure of common type acylphosphatase from bovine testis. , 1997, Structure.

[200]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[201]  L. Barron,et al.  Residual structure in unfolded proteins revealed by Raman optical activity. , 1996, Biochemistry.

[202]  Tracy M. Handel,et al.  Detection of rare partially folded molecules in equilibrium with the native conformation of RNaseH , 1996, Nature Structural Biology.

[203]  J R Glover,et al.  Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.

[204]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[205]  Alejandra del C. Alonso,et al.  Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.

[206]  S. Paushkin,et al.  Propagation of the yeast prion‐like [psi+] determinant is mediated by oligomerization of the SUP35‐encoded polypeptide chain release factor. , 1996, The EMBO journal.

[207]  J. Kelly,et al.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. , 1996, Biochemistry.

[208]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[209]  O. Ptitsyn,et al.  Further evidence on the equilibrium "pre-molten globule state": four-state guanidinium chloride-induced unfolding of carbonic anhydrase B at low temperature. , 1996, Journal of molecular biology.

[210]  G. Damaschun,et al.  Prothymosin alpha: a biologically active protein with random coil conformation. , 1995, Biochemistry.

[211]  R. Wickner,et al.  Prion-Inducing Domain of Yeast Ure2p and Protease Resistance of Ure2p in Prion-Containing Cells , 1995, Science.

[212]  K. Titani,et al.  Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.

[213]  O. Ptitsyn,et al.  Kinetic and equilibrium folding intermediates. , 1995, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[214]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[215]  Abnormally phosphorylated tau from Alzheimer disease brain depolymerizes microtubules A. del C. Alonso, I. Grundke-Iqbal and K. Iqbal. New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York 10314 USA , 1994, Neurobiology of Aging.

[216]  C. Dobson,et al.  Equilibrium unfolding studies of horse muscle acylphosphatase. , 1994, European journal of biochemistry.

[217]  E. Mandelkow,et al.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. , 1994, The Journal of biological chemistry.

[218]  C. Colaco,et al.  Amyloid fibril formation , 1994, Bio/Technology.

[219]  G. Marhaug,et al.  Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. , 1994, Bailliere's clinical rheumatology.

[220]  I. Grundke‐Iqbal,et al.  Alzheimer paired helical filaments Restoration of the biological activity by dephosphorylation , 1994, FEBS letters.

[221]  P. Limburg,et al.  Rapid automated enzyme immunoassay of serum amyloid A. , 1994, Clinical chemistry.

[222]  M. Hurle,et al.  A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[223]  Khadija Iqbal,et al.  Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[224]  R. Wickner,et al.  [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.

[225]  O. Ptitsyn,et al.  "Partly folded" state, a new equilibrium state of protein molecules: four-state guanidinium chloride-induced unfolding of beta-lactamase at low temperature. , 1994, Biochemistry.

[226]  M. Williamson,et al.  The structure and function of proline-rich regions in proteins. , 1994, The Biochemical journal.

[227]  K. Titani,et al.  In vivo phosphorylation sites in fetal and adult rat tau. , 1993, The Journal of biological chemistry.

[228]  S. Yen,et al.  The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments , 1993, Brain Research.

[229]  R. Brandt,et al.  The Balance Between τ Protein's Microtubule Growth and Nucleation Activities: Implications for the Formation of Axonal Microtubules , 1993, Journal of neurochemistry.

[230]  D. Brems,et al.  Acid stabilization of insulin. , 1993, Biochemistry.

[231]  I. Campbell,et al.  Solution structure and ligand-binding site of the SH3 domain of the p85α subunit of phosphatidylinositol 3-kinase , 1993, Cell.

[232]  D. Booth,et al.  Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.

[233]  R. Brandt,et al.  Functional organization of microtubule-associated protein tau. Identification of regions which affect microtubule growth, nucleation, and bundle formation in vitro. , 1993, The Journal of biological chemistry.

[234]  J. Wood,et al.  Functional studies of Alzheimer's disease tau protein , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[235]  M. Sternberg,et al.  Left-handed polyproline II helices commonly occur in globular proteins. , 1993, Journal of molecular biology.

[236]  R. Braun,et al.  Proline-directed phosphorylation of human Tau protein. , 1992, The Journal of biological chemistry.

[237]  J. R. Somoza,et al.  1H resonance assignments, secondary structure and general topology of single-chain monellin in solution as determined by1H 2D-NMR , 1992, Journal of biomolecular NMR.

[238]  A. Hyman,et al.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. , 1992, Molecular biology of the cell.

[239]  J. Buxbaum.  Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. , 1992, Hematology/oncology clinics of North America.

[240]  R J Williams,et al.  Three-dimensional structure of acylphosphatase. Refinement and structure analysis. , 1992, Journal of molecular biology.

[241]  T. Keiderling,et al.  Reassessment of the random coil conformation: Vibrational CD study of proline oligopeptides and related polypeptides , 1991, Biopolymers.

[242]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[243]  J. Bartek,et al.  Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. , 1991, Oncogene.

[244]  K. Sletten,et al.  Fibril in senile systemic amyloidosis is derived from normal transthyretin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[245]  M. Karplus,et al.  Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics. , 1989, Biochemistry.

[246]  E. Mandelkow,et al.  Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation , 1989, The Journal of cell biology.

[247]  R. J. Williams,et al.  The sequence-specific assignment of the 1H-NMR spectrum of an enzyme, horse-muscle acylphosphatase. , 1989, European journal of biochemistry.

[248]  R. J. Williams,et al.  Identification and description of beta-structure in horse muscle acylphosphatase by nuclear magnetic resonance spectroscopy. , 1989, Journal of molecular biology.

[249]  A. Himmler.  Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.

[250]  R. J. Williams,et al.  Identification and description of alpha-helical regions in horse muscle acylphosphatase by 1H nuclear magnetic resonance spectroscopy. , 1989, Journal of molecular biology.

[251]  V. Saudek,et al.  The structure and properties of horse muscle acylphosphatase in solution Mobility of antigenic and active site regions , 1989, FEBS letters.

[252]  C. Kay,et al.  Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.

[253]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[254]  M. A. Saper,et al.  Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.

[255]  D. W. Hayden,et al.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[256]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[257]  G. Reeke,et al.  Three-dimensional structure of beta 2-microglobulin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[258]  M. Saraiva,et al.  Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). , 1984, The Journal of clinical investigation.

[259]  N. Kallenbach,et al.  Hydrogen exchange and structural dynamics of proteins and nucleic acids , 1983, Quarterly Reviews of Biophysics.

[260]  E. Wilander,et al.  Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin , 1983, Diabetologia.

[261]  H. Watson,et al.  Sequence and structure of yeast phosphoglycerate kinase. , 1982, The EMBO journal.

[262]  G. Ramponi,et al.  Hydrolysis by horse muscle acylphosphatase of (Ca2+ + Mg2+)-ATPase phosphorylated intermediate. , 1981, Archives of biochemistry and biophysics.

[263]  Akira Okano,et al.  Amyloid fibril protein in familial amyloid polyneuropathy , 1981, Neurology.

[264]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[265]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[266]  M. Benson,et al.  Fibrillar assemblage of variable segments of immunoglobulin light chains: an electron microscopic study. , 1973, Journal of immunology.

[267]  T. Blundell,et al.  Three-Dimensional Atomic Structure of Insulin and Its Relationship to Activity , 1972, Diabetes.

[268]  A. Cohen,et al.  HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRIL , 1967, The Journal of cell biology.

[269]  L. Hokin,et al.  Evidence that a phosphorylated intermediate in a brain transport adenosine triphosphatase is an acyl phosphate. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[270]  D. F. Waugh,et al.  Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils , 1953 .

[271]  D. F. Waugh.  A Fibrous Modification of Insulin. I. The Heat Precipitate of Insulin , 1946 .

[272]  D. Wiley,et al.  Structure of the human class I histocompatibility antigen, HLA-A2. , 2005, Journal of immunology.

[273]  V. Uversky,et al.  Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. , 2003, FEBS letters.

[274]  V. Uversky,et al.  Biophysical constraints for protein structure prediction. , 2003, Journal of proteome research.

[275]  C. Dobson,et al.  A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. , 2002, Protein science : a publication of the Protein Society.

[276]  V. Subramaniam,et al.  Amyloid fibrils from the mammalian protein prothymosin alpha. , 2002, FEBS letters.

[277]  V. Uversky,et al.  Conformational prerequisites for alpha-lactalbumin fibrillation. , 2002, Biochemistry.

[278]  Kiowa S. Bower,et al.  Accelerated alpha-synuclein fibrillation in crowded milieu. , 2002, FEBS letters.

[279]  Vladimir N Uversky,et al.  What does it mean to be natively unfolded? , 2002, European journal of biochemistry.

[280]  G. Rose.  Getting to know u. , 2002, Advances in protein chemistry.

[281]  R. Ribeiro,et al.  A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer , 2002, Nature Structural Biology.

[282]  Robert W Woody,et al.  Is polyproline II a major backbone conformation in unfolded proteins? , 2002, Advances in protein chemistry.

[283]  M. Hoshino,et al.  Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. , 2002, Nature structural biology.

[284]  J. Trojanowski,et al.  Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. , 2002, Neuron.

[285]  V. Uversky,et al.  Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro. , 2002, FEBS letters.

[286]  L. Barron,et al.  Unfolded proteins studied by Raman optical activity. , 2002, Advances in protein chemistry.

[287]  Z. Obradovic,et al.  Identification and functions of usefully disordered proteins. , 2002, Advances in protein chemistry.

[288]  W. Mcdougal.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.

[289]  Brigida Bochicchio,et al.  Polyproline II structure in proteins: identification by chiroptical spectroscopies, stability, and functions. , 2002, Chirality.

[290]  V. Uversky,et al.  The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. , 2002, The Journal of biological chemistry.

[291]  S. Radford,et al.  Structural properties of an amyloid precursor of beta(2)-microglobulin. , 2002, Nature structural biology.

[292]  Ewan W Blanch,et al.  A Raman optical activity study of rheomorphism in caseins, synucleins and tau. New insight into the structure and behaviour of natively unfolded proteins. , 2002, European journal of biochemistry.

[293]  E. Žerovnik,et al.  Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. , 2002, European journal of biochemistry.

[294]  D. Price,et al.  Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[295]  A Keith Dunker,et al.  Intrinsic disorder and protein function. , 2002, Biochemistry.

[296]  M. Goedert.  Parkinson's disease and other alpha-synucleinopathies. , 2001, Clinical chemistry and laboratory medicine.

[297]  M. Goedert.  The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. , 2001, Current opinion in genetics & development.

[298]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[299]  V. Uversky,et al.  Trimethylamine-N-oxide-induced folding of alpha-synuclein. , 2001, FEBS letters.

[300]  Christopher J. Oldfield,et al.  Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.

[301]  N. Heegaard,et al.  Conformational Intermediate of the Amyloidogenic Protein (cid:1) 2 -Microglobulin at Neutral pH* , 2001 .

[302]  C. Cotman,et al.  Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's A beta peptide. , 2000, Biochemistry.

[303]  L. Berliner,et al.  alpha-Lactalbumin: structure and function. , 2000, FEBS letters.

[304]  H. Zoghbi,et al.  Trinucleotide repeats: mechanisms and pathophysiology. , 2000, Annual review of genomics and human genetics.

[305]  P. Lansbury,et al.  Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. , 2000, Annals of the New York Academy of Sciences.

[306]  C. Dobson,et al.  Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB , 1999, Protein science : a publication of the Protein Society.

[307]  C. Murphy,et al.  In vitro immunoglobulin light chain fibrillogenesis. , 1999, Methods in enzymology.

[308]  S. Lindquist,et al.  [PSI+]: an epigenetic modulator of translation termination efficiency. , 1999, Annual review of cell and developmental biology.

[309]  S. Lindquist,et al.  Yeast prion [psi +] and its determinant, Sup35p. , 1999, Methods in enzymology.

[310]  A. Delacourte,et al.  Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.

[311]  R. Wetzel.  Domain stability in immunoglobulin light chain deposition disorders. , 1997, Advances in protein chemistry.

[312]  A. Arabshahi,et al.  [6] Second virial coefficient as predictor in protein crystal growth. , 1997, Methods in enzymology.

[313]  O. Ptitsyn,et al.  Molten globule and protein folding. , 1995, Advances in protein chemistry.

[314]  A. Fink.  Compact intermediate states in protein folding. , 1995, Annual review of biophysics and biomolecular structure.

[315]  H. Taguchi,et al.  [Molecular chaperone]. , 1994, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[316]  I. Campbell,et al.  Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. , 1993, Cell.

[317]  A. Gown,et al.  Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. , 1992, The American journal of pathology.

[318]  T. Blundell,et al.  The crystal structure of rhombohedral 2 zinc insulin. , 1972, Cold Spring Harbor symposia on quantitative biology.

[319]  J. Ehrlich,et al.  Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals. , 1961, The American journal of pathology.

[320]  A. J. Clifford,et al.  BIOCHIMICA ET BIOPHYSICA ACTA , 2022 .